CG
ICPT
Carmignac Gestion’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-85,271
| Closed | -$1.58M | – | 163 |
|
|
2023
Q3 | $1.58M | Buy |
+85,271
| New | +$1.58M | 0.03% | 107 |
|
|
2017
Q3 | – | Sell |
-2,035,592
| Closed | -$246M | – | 77 |
|
|
2017
Q2 | $246M | Buy |
2,035,592
+7,400
| +0.4% | +$896K | 2% | 21 |
|
|
2017
Q1 | $229M | Buy |
2,028,192
+5,400
| +0.3% | +$611K | 1.76% | 24 |
|
|
2016
Q4 | $220M | Buy |
2,022,792
+7,600
| +0.4% | +$826K | 1.71% | 26 |
|
|
2016
Q3 | $332M | Buy |
2,015,192
+21,600
| +1% | +$3.56M | 2.48% | 16 |
|
|
2016
Q2 | $284M | Buy |
1,993,592
+326,855
| +20% | +$46.6M | 2.43% | 18 |
|
|
2016
Q1 | $214M | Buy |
1,666,737
+346,850
| +26% | +$44.6M | 2.09% | 22 |
|
|
2015
Q4 | $197M | Buy |
1,319,887
+380
| +0% | +$56.8K | 2.17% | 19 |
|
|
2015
Q3 | $219M | Sell |
1,319,507
-5,100
| -0.4% | -$846K | 2.77% | 17 |
|
|
2015
Q2 | $320M | Sell |
1,324,607
-24,780
| -2% | -$5.98M | 2.85% | 15 |
|
|
2015
Q1 | $381M | Sell |
1,349,387
-82,684
| -6% | -$23.3M | 3.37% | 14 |
|
|
2014
Q4 | $223M | Buy |
1,432,071
+101,555
| +8% | +$15.8M | 2.04% | 22 |
|
|
2014
Q3 | $315M | Buy |
1,330,516
+329,940
| +33% | +$78.1M | 2.69% | 18 |
|
|
2014
Q2 | $237M | Buy |
+1,000,576
| New | +$237M | 1.85% | 24 |
|